These results suggest that the role of NF90 in stabilizing VEGF during cancer-induced hypoxia might be the result of NF90 interfering with Ago2 binding to VEGF mRNA and, consequently, reduced targeting of VEGF mRNA by RISC activity. The gene discussed is VEGFA; the disease is cancer.